Assessment of the Potential Adverse Events Related to Ribavirin-Interferon Combination for Novel Coronavirus Therapy

Table 1

Two-by-two frequency table.

	Adverse event of interest	All other adverse events	Total
Drug of interest
All other drugs
Total